XML 40 R25.htm IDEA: XBRL DOCUMENT v3.19.1
REVENUE RECOGNITION (Tables)
12 Months Ended
Jan. 31, 2019
ASU 2014-09  
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]  
Schedule of impact of adopting ASC 606

The following tables summarize the impact of adopting ASC 606 on the Company’s Consolidated Balance Sheet as of January 31, 2019 and the Company’s Consolidated Statements of Income and Comprehensive Income for the year ended January 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

January 31, 2019

 

 

(In thousands)

 

    

As Reported

    

Without Adoption
of ASC 606

    

Impact of Adoption
of ASC 606

Assets

 

 

 

 

 

 

 

 

 

Accounts receivable

 

$

502,133

 

$

322,785

 

$

179,348

Inventories

 

 

576,383

 

 

618,902

 

 

(42,519)

Prepaid expenses and other current assets

 

 

96,933

 

 

58,792

 

 

38,141

Deferred income tax assets, net

 

 

22,427

 

 

5,883

 

 

16,544

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

Accrued expenses

 

 

(102,841)

 

 

(102,425)

 

 

(416)

Customer refund liabilities

 

 

(243,589)

 

 

 —

 

 

(243,589)

 

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

Retained earnings

 

 

(758,881)

 

 

(811,372)

 

 

52,491

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended January 31, 2019

 

 

(In thousands, except per share amounts)

 

    

As Reported

    

Without Adoption
of ASC 606

    

Impact of  Adoption
of ASC 606

Net sales

 

$

3,076,208

 

$

3,099,114

 

$

(22,906)

Cost of goods sold

 

 

1,969,099

 

 

1,965,153

 

 

3,946

Selling, general and administrative expenses

 

 

834,763

 

 

863,261

 

 

(28,498)

Operating profit

 

 

230,714

 

 

229,067

 

 

1,647

Income tax expense

 

 

45,763

 

 

45,353

 

 

410

Net income

 

 

138,067

 

 

136,830

 

 

1,237

 

 

 

 

 

 

 

 

 

 

Net income per common share

 

 

 

 

 

 

 

 

 

Basic

 

 

2.81

 

 

2.78

 

 

0.03

Diluted

 

 

2.75

 

 

2.72

 

 

0.03